🇺🇸 FDA
Patent

US 12343324

Dihydromyricetin hot melt extrusion formulations and methods for forming them

granted A61KA61K31/352A61K31/353

Quick answer

US patent 12343324 (Dihydromyricetin hot melt extrusion formulations and methods for forming them) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/352, A61K31/353, A61K45/06, A61K47/10